Small-molecule therapeutic - Minerva Boitechnologies
Latest Information Update: 11 Aug 2022
At a glance
- Originator Minerva Biotechnologies
- Class Antineoplastics; Small molecules
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Research Solid tumours
Most Recent Events
- 01 Sep 2020 Early research in Solid tumours in USA (unspecified route) (Minarva Boitechnologies pipeline, September 2020)